Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Cancer

Volumn 101, Issue 5, 2004, Pages 1009-1017

  Yuan, Jian Min ^a   Govindarajan, Sugantha ^b   Arakawa, Kazuko ^a   Yu, Mimi C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

Author keywords

Alcohol; Diabetes; Hepatocellular carcinoma (HCC); Obesity; Tobacco; Viral hepatitis

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; CANCER RISK; CAUCASIAN; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENDER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISPANIC; HUMAN; HUMAN TISSUE; LIFESTYLE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; TOBACCO; UNITED STATES; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER NEOPLASMS; LOS ANGELES; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SMOKING;

EID: 4143065907     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20427     Document Type: Article

References (41)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas D. Cancer incidence in five continents. Volume VIII. IARC Scientific Pub. No. 155. Lyon: International Agency for Research on Cancer, 2002.
2. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2:1129-1133.
3. Blumberg BS, London WT. Hepatitis B virus and the prevention of primary cancer of the liver. J Natl Cancer Inst. 1985; 74:267-273.
4. Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 1989;49:2506-2509.
5. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol. 2000;14:703-709.
6. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst. 1991;83:1820-1826.
7. Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002; 155:323-331.
8. Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002;36:1206-1213.
9. Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R. Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer. 2003;107:106-112.
10. Wang LY, You SL, Lu SN, et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 2003;14:241-250.
11. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750.
12. Yu MC, Yuan JM, Ross RK, Govindarajan S. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. Hepatology. 1997;25:226-228.
13. Surveillance, Epidemiology, and End Results (SEER) program (available from URL: www.seer.cancer.gov). Publicuse data (1973-2000). Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2003 [released April 2003, based on the November 2002 submission].
14. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1. The analysis of case-control studies. IARC Sci. Pub. No. 32. Lyon: International Association for Research on Cancer, 1980.
15. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol. 1976;103:506-511.
16. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst. 1990;82:1038-1041.
17. Hassan MM, Frome A, Patt YZ, El-Serag HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2002;35:266-269.
18. Roizen R, Kerr WC, Fillmore KM. Cirrhosis mortality and per capita consumption of distilled spirits, United States, 1949-94: trend analysis. BMJ. 1999;319:666-670.
19. Reinke LA, Moore DR, McCay PB. Free radical formation in livers of rats treated acutely and chronically with alcohol. Alcohol Clin Exp Res. 1997;21:642-646.
20. Reinke LA, Moore DR, Nanji AA. Pronounced hepatic free radical formation precedes pathological liver injury in ethanol-fed rats. Alcohol Clin Exp Res. 2000;24:332-335.
21. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine [comment]. Lancet. 1993; 341:454-457.
22. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr. 1995;61:549-554.
23. Becker U, Gronbaek M, Johansen D, Sorensen TI. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology. 2002;35:868-875.
24. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol. 2001;96:2462-2467.
25. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology. 1984;87:688-694.
26. Gentile S, Loguercio C, Marmo R, Carbone L, Del Vecchio Blanco C. Incidence of altered glucose tolerance in liver cirrhosis. Diabetes Res Clin Pract. 1993;22:37-44.
27. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin-dependent diabetes in America. 2nd edition. Publication No. 95-1468. Bethesda: National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 1995:47-88.
28. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care. 2000;23:1278-1283.
29. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
30. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.
31. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
32. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625-1638.
33. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology. 2001;121:710-723.
34. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30:1356-1362.
35. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664-669.
36. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet. 1985;1:1357-1360.
37. Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol. 2003;148:535-542.
38. Day CP. Is necroinflammation a prerequisite for fibrogenesis? Hepatogastroenterology. 1996;43:104-120.
39. Donato F, Tagger A, Chiesa R, et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology. 1997;26:579-584.
40. Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol. 1998;28:930-938.
41. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [comment]. N Engl J Med. 1999; 341:556-562.